Janux Therapeutics (JANX) EBT Margin (2021 - 2026)
Janux Therapeutics' (JANX) quarterly EBT Margin came in at 1416.02% in Q1 2026, down 7.96% on a QoQ basis from 1311.57% in Q3 2025.
Janux Therapeutics (JANX) EBT Margin (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of EBT Margin data on file, last reported at 1416.02% in Q1 2026.
- On a quarterly basis, EBT Margin changed N/A year-over-year to 1416.02% in Q1 2026; TTM through Mar 2026 was 2537.67%, a 613070.0% increase from a year earlier, with the FY2025 full-year figure at 1432.21%, up 263455.0% from the prior year.
- EBT Margin for Q1 2026 stood at 1416.02%, down from 1311.57% in the prior quarter.
- Over the last five years, EBT Margin for JANX reached as high as 477.77% in Q4 2023 and fell as low as 77800.68% in Q3 2024.
- Historically, EBT Margin has averaged 9503.19% across 5 years, with a median of 2680.08% in 2023.
- Across the five-year window, EBT Margin tumbled 7674212 bps in 2024 and soared 7648911 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 576.77% in 2022, then advanced by 17 bps to 477.77% in 2023, then tumbled by 16184 bps to 77800.68% in 2024, then jumped by 98 bps to 1311.57% in 2025, then slipped by 8 bps to 1416.02% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 1416.02% in Q1 2026, 1311.57% in Q3 2025, and 77800.68% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Janux Therapeutics | 985.11 Mn | 985.11 Mn | - | -1,416.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,416.02% |
| Sep 30, 2025 | -1,311.57% |
| Sep 30, 2024 | -77,800.68% |
| Jun 30, 2024 | -3,291.47% |
| Mar 31, 2024 | -21,446.96% |
| Dec 31, 2023 | -477.77% |
| Sep 30, 2023 | -1,058.56% |
| Jun 30, 2023 | -5,120.25% |
| Mar 31, 2023 | -2,680.08% |
| Dec 31, 2022 | -576.77% |
| Sep 30, 2022 | -3,001.32% |
| Jun 30, 2022 | -2,311.92% |
| Mar 31, 2022 | -3,048.08% |
| Dec 31, 2021 | -830.20% |
| Sep 30, 2021 | -7,199.22% |
| Jun 30, 2021 | -1,287.55% |
| Mar 31, 2021 | -601.05% |